申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:US03935268A1
公开(公告)日:1976-01-27
.omega.-[Bis(.omega.,.omega.-diphenylalkyl)amino]alkan-1-ol having the following formula: ##SPC1## And their pharmaceutically acceptable acid addition salts which are useful for preventing and treating cerebral vascural diseases caused by cerebral blood flow disorder, processes for preparing the compounds and pharmaceutical compositions containing the compound.
以下是该文本的中文翻译:
具有以下化学式的.omega.-[双(苯基烷基)氨基]烷基-1-醇:##SPC1##以及它们的药学上可接受的酸盐加合物,用于预防和治疗由脑血流障碍引起的脑血管疾病,制备该化合物的过程以及含有该化合物的制药组合物。